We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Secures $1.2 Billion Government Contract for Experimental COVID-19 Treatment
Merck Secures $1.2 Billion Government Contract for Experimental COVID-19 Treatment
The U.S. government will pay Merck an estimated $1.2 billion for 1.7 million courses of its experimental COVID-19 antiviral, molnupiravir, if the drug is authorized by the FDA.